The mitral valve is one of the most complex structures in the heart. When it becomes severely diseased, treatment may involve surgical repair, surgical replacement, transcatheter edge-to-edge repair or, in selected patients, transcatheter mitral valve replacement.

Transcatheter mitral valve replacement, commonly abbreviated as TMVR, is not simply a less-invasive version of routine mitral surgery. It is a specialised option used in carefully selected situations where anatomy, surgical risk and expected benefit support a catheter-based replacement strategy.

Because the mitral valve sits close to the left ventricular outflow tract, coronary structures and other important anatomy, patient selection requires detailed imaging and expert planning.

What Problems Can Lead to Mitral Valve Replacement?

Severe mitral regurgitation is one reason a patient may need intervention. In this condition, the valve does not close properly and blood leaks backward into the left atrium.

Mitral stenosis, in which the valve becomes narrowed and obstructs blood flow, is another problem that may eventually require intervention.

Treatment depends on the cause. Rheumatic disease, degenerative valve disease, severe mitral annular calcification and failure of a previous surgical valve can all create different anatomical challenges.

Why Is Surgery Still Important?

Conventional mitral surgery remains the standard treatment for many patients. Surgeons can repair or replace the valve under direct vision and can address other cardiac problems during the same operation.

For patients with primary degenerative mitral regurgitation and acceptable surgical risk, durable surgical repair may be preferred when it can be performed successfully.

TMVR becomes most relevant when surgery is considered high risk, repeat surgery is difficult or the anatomy creates a suitable opportunity for transcatheter treatment.

Failing Surgical Bioprosthetic Valves

One of the more established uses of transcatheter mitral replacement is valve-in-valve treatment for selected patients whose previous biological mitral valve has deteriorated.

Bioprosthetic valves can fail over time by becoming narrowed, leaky or both. Repeat open-heart surgery may carry increased risk, especially in older adults or patients who have already had several cardiac operations.

In appropriate anatomy, a new transcatheter valve may be implanted inside the failing surgical prosthesis.

Previous Annuloplasty Rings

Some patients previously underwent mitral valve repair with an annuloplasty ring. If the repaired valve later becomes severely dysfunctional, another operation may be required.

In selected high-risk patients, valve-in-ring transcatheter treatment may be considered. The shape, size and type of the existing ring affect whether a transcatheter valve can be anchored safely.

This strategy is technically complex and requires detailed CT planning.

Severe Mitral Annular Calcification

Mitral annular calcification can make conventional surgery difficult because calcium may extend around the valve ring and into surrounding structures.

In selected patients with severe symptoms and very high surgical risk, transcatheter treatment using the calcified annulus as part of the anchoring structure may be considered.

This approach carries specific risks, including valve migration, leakage and obstruction of the left ventricular outflow tract. It is therefore reserved for carefully selected cases at experienced centres.

Native Mitral Valve Disease

Transcatheter replacement in a native mitral valve remains more complex than TAVI in the aortic position. The mitral annulus is large, irregular and dynamic, and the native leaflets and supporting apparatus can interact with the replacement valve.

Dedicated transcatheter mitral devices continue to evolve. Patient selection depends on device availability, anatomy, clinical indication and the experience of the treating programme.

Patients considering TMVR in Mumbai should ask whether the proposed treatment is valve-in-valve, valve-in-ring, valve-in-mitral-annular-calcification or a dedicated native-valve replacement strategy.

Why CT Planning Is Critical

CT imaging is one of the most important tools in TMVR assessment. It allows the team to measure the annulus, understand the distribution of calcium and simulate how a new valve may sit inside the heart.

A major concern is left ventricular outflow tract obstruction. When a new mitral valve is implanted, the native anterior leaflet and valve frame can narrow the pathway through which blood leaves the left ventricle.

CT simulation estimates the size of the remaining outflow tract and helps identify patients in whom the risk may be unacceptable.

The Role of Echocardiography

Echocardiography defines the severity and mechanism of mitral disease, ventricular function, pulmonary pressures and other valve abnormalities.

Transoesophageal echocardiography provides more detailed views and is often used both for planning and during transcatheter procedures.

CT and echocardiography complement each other; neither should be viewed as optional in complex mitral replacement planning.

Could TEER Be an Alternative?

Some patients with mitral regurgitation may be better suited to repair rather than replacement. A MitraClip or another TEER procedure can reduce regurgitation by bringing the native leaflets together.

The Heart Team compares whether repair can achieve an adequate result, whether replacement is technically possible and how each option affects future treatment.

This is where consultation with experienced heart specialists in Mumbai can be particularly valuable for high-risk and previously operated patients.

What Happens After TMVR?

After transcatheter replacement, patients require monitoring for bleeding, rhythm problems, valve function and other procedure-specific complications.

The antithrombotic plan is individualised, and follow-up imaging is needed to assess the prosthetic valve and heart function.

Recovery may be shorter than repeat open-heart surgery in appropriately selected patients, but the clinical complexity of TMVR means follow-up remains intensive.

The Bottom Line

TMVR is considered when severe mitral valve disease requires intervention and a catheter-based replacement offers a reasonable alternative to high-risk surgery. Common scenarios include failing bioprosthetic valves, selected prior annuloplasty rings, severe mitral annular calcification and certain native-valve cases.

The procedure is not suitable for every patient. Detailed CT simulation, echocardiography and multidisciplinary Heart Team review are essential because mitral anatomy can create unique risks.

For complex mitral disease, the goal is not simply to avoid surgery. It is to choose the treatment that can be performed safely, produce meaningful valve improvement and fit the patient’s longer-term cardiac strategy.